Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: A comparison with C-reactive protein

European Journal of Haematology

Volumn 83, Issue 3, 2009, Pages 251-257

  Hämäläinen, Sari ^a   Juutilainen, Auni ^a,b   Matinlauri, Irma ^a   Kuittinen, Taru ^a   Ruokonen, Esko ^a   Koivula, Irma ^a   Jantunen, Esa ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

C reactive protein; Haematological patients; Neutropenic fever; Vascular endothelial growth factor

Indexed keywords

C REACTIVE PROTEIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IDARUBICIN; MELPHALAN; MITOXANTRONE; TIOGUANINE; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CULTURE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG MEGADOSE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPOTENSION; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; FEMALE; FEVER; HEMATOLOGIC DISEASES; HEMATOLOGY; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; STEM CELL TRANSPLANTATION; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68849107507     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01260.x     Document Type: Article

References (26)

1. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003 9 : 677 84.
2. Roy H, Bhardwaj S, Ylä-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006 580 : 2879 87.
3. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003 9 : 669 76.
4. Kroll J, Waltenberger J. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Biochem Biophys Res Commun 1999 265 : 636 9.
5. Hämäläinen S, Kuittinen T, Matinlauri I, Nousiainen T, Koivula I, Jantunen E. Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: causes and consequences. Leuk Lymphoma 2008 49 : 495 501.
6. Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis 1995 21 : 114 21.
7. Persson L, Engervall P, Magnuson A, Vikerfors T, Söderquist B, Hansson LO, Tidefelt U. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004 36 : 365 71.
8. Persson L, Söderquist B, Engervall P, Vikerfors T, Hansson LO, Tidefelt U. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol 2005 74 : 297 303.
9. Cassileth PA, Lee SJ, Litzow MR, et al. Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995). Leuk Lymphoma 2005 46 : 55 61.
10. Castaigne S, Chevret S, Archimbaud E, et al. Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study. Blood 2004 104 : 2467 74.
11. Koistinen P, Räty R, Itälä M, et al. Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group. Eur J Haematol 2007 78 : 477 86.
12. Jantunen E, Itälä M, Lehtinen T, et al. Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Eur J Haematol 2006 76 : 245 50.
13. Karlsson S, Pettilä V, Tenhunen J, Lund V, Hovilehto S, Ruokonen E. Vascular endothelial growth factor in severe sepsis and septic shock. Anesth Analg 2008 106 : 1820 6.
14. Pickkers P, Sprong T, Eijk L, Hoeven H, Smits P, Deuren M. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 2005 24 : 508 12.
15. van der Flier M, van Leeuwen HJ, van Kessel KP, Kimpen JL, Hoepelman AI, Geelen SP. Plasma vascular endothelial growth factor in severe sepsis. Shock 2005 23 : 35 8.
16. Hughes WT, Armstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002 34 : 730 51.
17. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCPSCCM Consensus Conference Committee. American College of Chest PhysiciansSociety of Critical Care Medicine. Chest 1992 101 : 1644 55.
18. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCMESICMACCPATSSIS International Sepsis Definitions Conference. Crit Care Med 2003 31 : 1250 6.
19. Yoden WJ. Index for rating diagnostic tests. Cancer 1950 3 : 32 5.
20. Choi JH, Kim HC, Lim HY, et al. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts. Lung Cancer 2001 33 : 171 9.
21. Gaudry M, Bregerie O, Andrieu V, El Benna J, Pocidalo MA, Hakim J. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997 90 : 4153 61.
22. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003 6 : 283 7.
23. Salven P, Orpana A, Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 1999 5 : 487 91.
24. Rafat N, Hanusch C, Brinkkoetter PT, Schulte J, Brade J, Zijlstra JG, van der Woude FJ, van Ackern K, Yard BA, Beck GCh. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med 2007 35 : 1677 84.
25. Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 2008 36 : 396 407.
26. Hämäläinen S, Kuittinen T, Matinlauri I, Nousiainen T, Koivula I, Jantunen E. Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome. Scand J Infect Dis 2009 41 : 14 20.